Are you Dr. Klekotka?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
Suite 5b
Saint Louis, MO 63110Phone+1 314-362-2643Fax+1 314-454-5626
Summary
- Dr. Paul Klekotka, MD is a board certified dermatologist in Saint Louis, Missouri. He is currently licensed to practice medicine in California.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 2003 - 2006- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2002 - 2003
- Washington University in St. Louis School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2010 - 2026- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 261 citationsA Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.Stephan R. Targan, Brian G. Feagan, Severine Vermeire, Remo Panaccione, Gil Y. Melmed
The American Journal of Gastroenterology. 2016-08-02 - 122 citationsEfficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.William J. Sandborn, Marc Ferrante, Bal R. Bhandari, Elina Berliba, Brian G. Feagan
Gastroenterology. 2020-02-01 - 188 citationsEfficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a StudyBruce E. Sands, Jingjing Chen, Brian G. Feagan, Mark Penney, William Rees
Gastroenterology. 2017-07-01
Grant Support
- Role Of NK Cells In Contact HypersensitivityNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2009
